Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Death with an implantable cardioverter-defibrillator: a MADIT-II substudy

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Temporal relations between atrial fibrillation and ischaemic stroke and their prognostic impact on mortality

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Catheter ablation for atrial fibrillation is associated with lower incidence of heart failure and death

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Aetiologies and temporal trends of atrioventricular block in young patients: a 20-year nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Clinical outcome in patients with implantable cardioverter-defibrillator and cancer: a nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Brugada syndrome: Let's talk about sex

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Fernando Chernomordik
  • Christian Jons
  • Helmut U Klein
  • Valentina Kutyifa
  • Eyal Nof
  • Wojciech Zareba
  • James P Daubert
  • Henry Greenberg
  • Michael Glikson
  • Ilan Goldenberg
  • Roy Beinart
View graph of relations

AIMS: There are limited data regarding factors that identify implantable cardioverter-defibrillator (ICD) patients who will experience either ventricular tachyarrhythmic (VTA) or non-arrhythmic (NA) mortality, and the commonly used clinical classification of sudden cardiac death (SCD) vs. non-sudden cardiac death (NSCD) may not be accurate enough. We aimed to correlate clinical adjudication of mortality events to device interrogation data and to identify risk factors for VTA mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).

METHODS AND RESULTS: Of the 746 patients who received an ICD in MADIT-II, 44 died from cardiac causes and had available interrogation data at the time of death. Sudden cardiac death vs. NSCD was defined by an adjudication committee. Ventricular tachyarrhythmic and NA arrhythmic deaths were categorized by the presence or absence of ventricular tachycardia or fibrillation (VT/VF) during the terminal event. Mode of death was found to be inaccurate when validated by device interrogation for VTA events: 50% patients adjudicated as SCD did not have a VTA event at the time of death; and 25% of adjudicated NSCD were found to have VT/VF during the mortality event. Multivariate analysis showed that factors independently associated with VTA mortality included: VT/VF >72 h prior to the mortality event [hazard ratio (HR) 8.0; P < 0.001], hospitalization for heart failure (HR 6.7; P = 0.001), and a history of hypertension (HR 4; P = 0.04).

CONCLUSION: Current classification of SCD vs. NSCD fails to identify VTA events at the time of death in a significant proportion of patients, and simple clinical parameters can be used to identify ICD recipients with increased risk for VTA mortality.

Original languageEnglish
JournalEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Volume21
Issue number12
Pages (from-to)1843-1850
Number of pages8
ISSN1099-5129
DOIs
Publication statusPublished - 2020

    Research areas

  • Arrhythmic death, Implantable cardioverter-defibrillator, MADIT-II, Sudden cardiac death

ID: 59172423